Clinical Trials List
Protocol NumberRLY-4008-101
2021-08-15 - 2024-08-31
Phase I
Recruiting1
ICD-10C22.1
Intrahepatic bile duct carcinoma
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9155.1
Malignant neoplasm of intrahepatic bile ducts
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chang-Fang Chiu Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
400 participants
